METROGEL (metronidazole) by Galderma is 12. First approved in 2005.
Drug data last refreshed 16h ago · AI intelligence enriched 19h ago
METROGEL is a topical 1% metronidazole gel indicated for rosacea treatment, supplied by Galderma. The mechanism of action in rosacea remains unknown, though metronidazole is a nitroimidazole antimicrobial. Topical application results in minimal systemic absorption (<1% of oral dosing).
As LOE approaches after 19+ years on market, brand teams face declining revenue and potential consolidation, signaling reduced headcount and transition to lifecycle management roles.
12.1 Mechanism of Action The mechanism of action of metronidazole in the treatment of rosacea is unknown. 12.2 Pharmacodynamics The pharmacodynamics of metronidazole in association with the treatment of rosacea are unknown. Cardiac Electrophysiology: The effect of Metronidazole Gel, 1% on the QTc…
Nitroimidazole Antimicrobial
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
Worked on METROGEL at Galderma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moMETROGEL offers limited career growth opportunities given its LOE trajectory and minimal linked job postings. Professionals working on this product will focus on defensive strategies, generic competition management, and potential transition planning.